VAERS 2671001
GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge 4ZN3H
- Staat
- PA
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 14.08.2023
- Impfdatum
- 25.07.2023
- Beginn
- 25.07.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Symptomtext
adult patient was given a pediatric dose of Engerix-B.; adult patient was given a pediatric dose of Engerix-B.; This non-serious case was reported by a nurse via call center representative and described the occurrence of underdose in a 56-year-old male patient who received HBV (Engerix B 10 mcg) (batch number 4ZN3H, expiry date 28-MAR-2025) for prophylaxis. On 25-JUL-2023, the patient received Engerix B 10 mcg. On 25-JUL-2023, an unknown time after receiving Engerix B 10 mcg, the patient experienced underdose (Verbatim: adult patient was given a pediatric dose of Engerix-B.) and adult use of a child product (Verbatim: adult patient was given a pediatric dose of Engerix-B.). The outcome of the underdose and adult use of a child product were unknown. Additional Information: Receipt date: 10-AUG-2023 The nurse reported an adult patient was given a pediatric dose of Engerix-B, which led to underdose and adult use of a child product. The vaccine administration facility is the same as primary reporter. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
